The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•14 April 2026•

1 min read

RAAPID Secures Strategic Investment Trifecta with Microsoft, Healthworx, and UPMC

Satya Nadella above an Xbox Game Pass sign showing a price drop from $16.99 to $6.99. Game covers and silhouetted people below.

Key Facts

1RAAPID secured a strategic investment from Healthworx, the investment arm of CareFirst, Inc.

2RAAPID is now the only risk adjustment platform backed simultaneously by Microsoft (M12), UPMC Enterprises, and Healthworx.

RAAPID, Inc. has successfully completed a strategic investment round featuring Healthworx, the investment arm of CareFirst, Inc., marking a significant milestone in healthcare technology. This move establishes RAAPID as the industry's only risk adjustment platform backed simultaneously by Microsoft (M12), UPMC Enterprises, and Healthworx. The strategic 'trifecta' aims to accelerate the adoption of AI-driven risk adjustment solutions and standardize defensible data across technology providers, health systems, and payers. By leveraging this collective expertise, RAAPID intends to transform how healthcare organizations manage financial and clinical risk. The backing from major industry players validates the company's technological edge and market position within the competitive healthcare AI sector. This development is particularly noteworthy for Microsoft's venture portfolio as it continues to deepen its footprint in specialized AI applications.